These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21904895)

  • 1. Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.
    Olsson SK; Larsson MK; Erhardt S
    J Neural Transm (Vienna); 2012 Feb; 119(2):155-63. PubMed ID: 21904895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.
    Liu XC; Holtze M; Powell SB; Terrando N; Larsson MK; Persson A; Olsson SK; Orhan F; Kegel M; Asp L; Goiny M; Schwieler L; Engberg G; Karlsson H; Erhardt S
    Brain Behav Immun; 2014 Feb; 36():80-9. PubMed ID: 24140727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.
    Rassoulpour A; Wu HQ; Poeggeler B; Schwarcz R
    Brain Res; 1998 Aug; 802(1-2):111-8. PubMed ID: 9748528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
    Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
    Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
    Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
    J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
    Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
    Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
    Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
    Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress.
    García-Lara L; Pérez-Severiano F; González-Esquivel D; Elizondo G; Segovia J
    J Neurosci Res; 2015 Sep; 93(9):1423-33. PubMed ID: 26013807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
    Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
    Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
    Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
    Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous kynurenic acid disrupts prepulse inhibition.
    Erhardt S; Schwieler L; Emanuelsson C; Geyer M
    Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
    Erhardt S; Engberg G
    Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenate production by cultured human astrocytes.
    Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
    J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.